BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17290585)

  • 1. Surgical pathologic factors in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection: association with administration of adjuvant radiotherapy and effect on survival.
    Piura B; Rabinovich A; Friger M
    Eur J Gynaecol Oncol; 2006; 27(6):573-8. PubMed ID: 17290585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Number and distribution of pelvic lymph nodes and effect of surgical pathologic factors on pelvic lymph node status in patients with early-stage cervical carcinoma treated with radical hysterectomy and pelvic lymph node dissection.
    Piura B; Rabinovich A; Friger M
    Eur J Gynaecol Oncol; 2006; 27(5):463-6. PubMed ID: 17139979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent cervical carcinoma after radical hysterectomy and pelvic lymph node dissection: a study of 32 cases.
    Piura B; Rabinovich A; Friger M
    Eur J Gynaecol Oncol; 2008; 29(1):31-6. PubMed ID: 18386460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in FIGO stage IB cervical cancer without lymph node metastasis and the role of adjuvant radiotherapy after radical hysterectomy.
    Ayhan A; Al RA; Baykal C; Demirtas E; Ayhan A; Yüce K
    Int J Gynecol Cancer; 2004; 14(2):286-92. PubMed ID: 15086728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk group in node-positive patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Aoki Y; Sasaki M; Watanabe M; Sato T; Tsuneki I; Aida H; Tanaka K
    Gynecol Oncol; 2000 May; 77(2):305-9. PubMed ID: 10785483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of disease as an indication for pelvic radiation following radical hysterectomy and bilateral pelvic lymph node dissection in the treatment of stage IB and IIA cervical carcinoma.
    Monk BJ; Cha DS; Walker JL; Burger RA; Ramsinghani NS; Manetta A; DiSaia PJ; Berman ML
    Gynecol Oncol; 1994 Jul; 54(1):4-9. PubMed ID: 8020837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Long-term oncological outcomes after laparoscopic versus abdominal radical hysterectomy in stage I a2- II a2 cervical cancer: a matched cohort study].
    Wang W; Shang C; Huang J; Chen S; Shen H; Yao S
    Zhonghua Fu Chan Ke Za Zhi; 2015 Dec; 50(12):894-901. PubMed ID: 26887872
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Results of different postoperative adjuvant therapies for stage Ib-IIa cervical carcinoma with risk factors].
    Wen HW; Huang WP; Liu TY; Ma K; Tao X; Zhu LR; Liao QP
    Zhonghua Fu Chan Ke Za Zhi; 2013 Dec; 48(12):920-4. PubMed ID: 24495686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors affecting disease-free survival in early-stage cervical cancer patients undergoing radical hysterectomy and pelvic-paraaortic lymphadenectomy.
    Metindir J; Bilir G
    Eur J Gynaecol Oncol; 2007; 28(1):28-32. PubMed ID: 17375702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative nomogram for the prediction of disease-free survival in lymph node-negative stage I-IIA cervical cancer patients treated with radical hysterectomy.
    Gülseren V; Kocaer M; Çakır İ; Özdemir İA; Sancı M; Güngördük K
    J Obstet Gynaecol; 2020 Jul; 40(5):699-704. PubMed ID: 31607197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early stage cervical cancer: adjuvant treatment in negative lymph node cases.
    Sartori E; Tisi G; Chiudinelli F; La Face B; Franzini R; Pecorelli S
    Gynecol Oncol; 2007 Oct; 107(1 Suppl 1):S170-4. PubMed ID: 17765298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors and prognosis of node-positive cervical carcinoma].
    Feng SY; Zhang YN; Liu JG
    Ai Zheng; 2005 Oct; 24(10):1261-6. PubMed ID: 16219145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Operable stage IB and II cancer of the uterine neck: retrospective comparison between preoperative utero-vaginal curietherapy and initial surgery followed by radiotherapy].
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Ganansia V; Bernard A; Antoine JM; Jannet D; Lhuillier PE; Uzan M; Genestie C; Antoine M; Jamali M; Milliez J; Uzan S; Blondon J
    Cancer Radiother; 2002 Jun; 6(4):217-37. PubMed ID: 12224488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for recurrence in patients with stage IB, IIA, and IIB cervical carcinoma after radical hysterectomy and postoperative pelvic irradiation.
    Lin HH; Cheng WF; Chan KW; Chang DY; Chen CK; Huang SC
    Obstet Gynecol; 1996 Aug; 88(2):274-9. PubMed ID: 8692515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early cervical carcinoma: the natural history of lymph node involvement redefined on the basis of thorough parametrectomy and giant section study.
    Benedetti-Panici P; Maneschi F; D'Andrea G; Cutillo G; Rabitti C; Congiu M; Coronetta F; Capelli A
    Cancer; 2000 May; 88(10):2267-74. PubMed ID: 10820348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of effect of tumor size on the prognosis of carcinoma of the uterine cervix Stage IB and IIA treated with preoperative irradiation and surgery.
    Grigsby PW; Perez CA; Chao KS; Elbendary A; Herzog TJ; Rader JS; Mutch DG
    Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):645-51. PubMed ID: 10524418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of adjuvant radiotherapy on oncological outcomes in patients with early-stage cervical carcinoma with only intermediate-risk factors: a propensity score matching analysis.
    Turkmen O; Kilic F; Tokalioglu AA; Cakir C; Yuksel D; Kilic C; Boran N; Kimyon Comert G; Turan T
    J Obstet Gynaecol; 2022 Oct; 42(7):3204-3211. PubMed ID: 35959796
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy.
    Takeda N; Sakuragi N; Takeda M; Okamoto K; Kuwabara M; Negishi H; Oikawa M; Yamamoto R; Yamada H; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 Dec; 81(12):1144-51. PubMed ID: 12519111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathologic complete remission after preoperative intracavitary radiotherapy of cervical cancer stage Ib and IIa is a strong prognostic factor for long-term survival: analysis of the Radiumhemmet data 1989-1991.
    Beskow C; Agren-Cronqvist AK; Granath F; Frankendal B; Lewensohn R
    Int J Gynecol Cancer; 2002; 12(2):158-70. PubMed ID: 11975675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.